320 related articles for article (PubMed ID: 31001256)
1. PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation.
Mizuno R; Sugiura D; Shimizu K; Maruhashi T; Watada M; Okazaki IM; Okazaki T
Front Immunol; 2019; 10():630. PubMed ID: 31001256
[TBL] [Abstract][Full Text] [Related]
2. The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood.
Sage PT; Francisco LM; Carman CV; Sharpe AH
Nat Immunol; 2013 Feb; 14(2):152-61. PubMed ID: 23242415
[TBL] [Abstract][Full Text] [Related]
3. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.
Bennett F; Luxenberg D; Ling V; Wang IM; Marquette K; Lowe D; Khan N; Veldman G; Jacobs KA; Valge-Archer VE; Collins M; Carreno BM
J Immunol; 2003 Jan; 170(2):711-8. PubMed ID: 12517932
[TBL] [Abstract][Full Text] [Related]
4. AP-1 is involved in ICOS gene expression downstream of TCR/CD28 and cytokine receptor signaling.
Watanabe M; Nakajima S; Ohnuki K; Ogawa S; Yamashita M; Nakayama T; Murakami Y; Tanabe K; Abe R
Eur J Immunol; 2012 Jul; 42(7):1850-62. PubMed ID: 22585681
[TBL] [Abstract][Full Text] [Related]
5. Inducible costimulator facilitates T-dependent B cell activation by augmenting IL-4 translation.
Gigoux M; Lovato A; Leconte J; Leung J; Sonenberg N; Suh WK
Mol Immunol; 2014 May; 59(1):46-54. PubMed ID: 24486724
[TBL] [Abstract][Full Text] [Related]
6. Mathematical modeling identifies Lck as a potential mediator for PD-1 induced inhibition of early TCR signaling.
Arulraj T; Barik D
PLoS One; 2018; 13(10):e0206232. PubMed ID: 30356330
[TBL] [Abstract][Full Text] [Related]
7. PD-1 Controls Follicular T Helper Cell Positioning and Function.
Shi J; Hou S; Fang Q; Liu X; Liu X; Qi H
Immunity; 2018 Aug; 49(2):264-274.e4. PubMed ID: 30076099
[TBL] [Abstract][Full Text] [Related]
8. Activated inducible co-stimulator-positive programmed cell death 1-positive follicular helper T cells indicate disease activity and severity in ulcerative colitis patients.
Long Y; Zhao X; Liu C; Xia C; Liu C
Clin Exp Immunol; 2020 Oct; 202(1):106-118. PubMed ID: 32621310
[TBL] [Abstract][Full Text] [Related]
9. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
Front Immunol; 2018; 9():1955. PubMed ID: 30214445
[No Abstract] [Full Text] [Related]
10. Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.
Olguín-Contreras LF; Mendler AN; Popowicz G; Hu B; Noessner E
Front Immunol; 2021; 12():750478. PubMed ID: 34912334
[TBL] [Abstract][Full Text] [Related]
11. A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.
Arimura Y; Kato H; Dianzani U; Okamoto T; Kamekura S; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T; Yagi J
Int Immunol; 2002 Jun; 14(6):555-66. PubMed ID: 12039907
[TBL] [Abstract][Full Text] [Related]
12. Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.
Pedros C; Altman A; Kong KF
Front Immunol; 2018; 9():2412. PubMed ID: 30405612
[TBL] [Abstract][Full Text] [Related]
13. TCR and CD28 Concomitant Stimulation Elicits a Distinctive Calcium Response in Naive T Cells.
Xia F; Qian CR; Xun Z; Hamon Y; Sartre AM; Formisano A; Mailfert S; Phelipot MC; Billaudeau C; Jaeger S; Nunès JA; Guo XJ; He HT
Front Immunol; 2018; 9():2864. PubMed ID: 30564247
[TBL] [Abstract][Full Text] [Related]
14. The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo.
Akiba H; Takeda K; Kojima Y; Usui Y; Harada N; Yamazaki T; Ma J; Tezuka K; Yagita H; Okumura K
J Immunol; 2005 Aug; 175(4):2340-8. PubMed ID: 16081804
[TBL] [Abstract][Full Text] [Related]
15. ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2.
Weber JP; Fuhrmann F; Feist RK; Lahmann A; Al Baz MS; Gentz LJ; Vu Van D; Mages HW; Haftmann C; Riedel R; Grün JR; Schuh W; Kroczek RA; Radbruch A; Mashreghi MF; Hutloff A
J Exp Med; 2015 Feb; 212(2):217-33. PubMed ID: 25646266
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death protein 1 activation preferentially inhibits CD28.CAR-T cells.
Zolov SN; Rietberg SP; Bonifant CL
Cytotherapy; 2018 Oct; 20(10):1259-1266. PubMed ID: 30309710
[TBL] [Abstract][Full Text] [Related]
17. Collaboration of TCR-, CD4- and CD28-mediated signalling in antigen-specific MHC class II-restricted T-cells.
Gogolák P; Réthy B; Horváth A; Tóth GK; Cervenák L; László G; Rajnavölgyi E
Immunol Lett; 1996 Dec; 54(2-3):135-44. PubMed ID: 9052868
[TBL] [Abstract][Full Text] [Related]
18. Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond.
Panneton V; Chang J; Witalis M; Li J; Suh WK
Immunol Rev; 2019 Sep; 291(1):91-103. PubMed ID: 31402504
[TBL] [Abstract][Full Text] [Related]
19. Molecular Dynamics of Co-signal Molecules in T-Cell Activation.
Saito T
Adv Exp Med Biol; 2019; 1189():135-152. PubMed ID: 31758533
[TBL] [Abstract][Full Text] [Related]
20. Changes in the strength of co-stimulation through the B7/CD28 pathway alter functional T cell responses to altered peptide ligands.
Murtaza A; Kuchroo VK; Freeman GJ
Int Immunol; 1999 Mar; 11(3):407-16. PubMed ID: 10221652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
